Curative Potential of Foremost Mitogen Applications

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 6, 2003, Pages 903-916

  Wimer, Bruce M ^a  

^a JBMW Immunotherapeutics   (United States)

Author keywords

Augmented myeloproliferation; Effective treatment of infections; Generalized non specific immunostimulation; Immune competence reconstitution; Malignant tumors; Mitogen therapy; Potential for lasting cures; Specified advantages of PHA and PWM

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; EPRATUZUMAB; ERYTHROPOIETIN; FLUDARABINE; FRACTION 4 PHYTOHEMAGGLUTININ; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOSPAN; IMMUNOSUPPRESSIVE AGENT; LECTIN; MITOGENIC AGENT; MONOCLONAL ANTIBODY; PERFLUOROOCTYL BROMIDE; PHYTOHEMAGGLUTININ; PHYTOHEMAGGLUTININ L4; POKEWEED MITOGEN; POLYMERIZED HEMOGLOBIN; PREDNISONE; RITUXIMAB; SMALLPOX VACCINE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOCARCINOMA; AGING; ALZHEIMER DISEASE; ANTHRAX; APLASTIC ANEMIA; BRAIN INJURY; CANCER; CANCER IMMUNOTHERAPY; CHERNOBYL ACCIDENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CYTOTOXICITY; DRUG HYPERSENSITIVITY; DRUG POTENCY; FIBROSARCOMA; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NERVE REGENERATION; NONHODGKIN LYMPHOMA; NONHUMAN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SMALLPOX; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 0347569582     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803322702879     Document Type: Review

References (23)

1. Mann PL, Eschima D, Bitner DM, et al. Biomodulation: An integrated approach to access and manipulate biological information. In: Gabius H-J, Gabius S, eds. Lectins and Cancer. Berlin, Heidelberg, New York, Tokyo: Springer-Verlag, 1991:179.
2. Wimer BM, Mann PL. Apparent pokeweed mitogen cure of metastatic gum melanoma in an older dog. Cancer Biother Radiopharm 2000;15:201.
3. Wimer BM. Therapeutic immunostimulating effects of plant mitogens exemplified by the L4 isolectin of PHA. Cancer Biother Radiopharm 1997;12:195.
4. Rai KR, Dohner H, Keating MJ, Montserrat E. Chronic lymphocytic leukemia: Case-based session. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:140.
5. Appelbaum FR, Rowe JM, Radich J, Dick JE. Acute myeloid leukemia. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:62.
6. Dalton WS, Bergsagel PL, Kuehl WM, et al. Multiple myeloma. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:157.
7. Linch DC, Gosden RG, Tulandi T, et al. Hodgkin's lymphoma: Choice of therapy and late complications. In: Schechter GP, ed. Hematology 2000. American Society of Hematology Education Program Book, 42nd Annual Meeting of the American Society of Hematology. San Francisco, CA, December 1-5, 2000:205.
8. Harris NL, Stein H, Coupland SE, et al. New approaches to lymphoma diagnosis. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:194.
9. Press OW, Leonard JP, Coiffier B, et al. Immunotherapy of non-Hodgkin's lymphomas. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:221.
10. Young NS, Abkowitz JL, Luzzatto L. New insights into the pathophysiology of acquired cytopenias. In: Schechter GP, ed. Hematology 2000. American Society of Hematology Education Program Book, 42nd Annual Meeting of the American Society of Hematology. San Francisco, CA, December 1-5, 2000:18.
11. Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes. In: Broudy VC, ed. Hematology 2002. American Society of Hematology Education Program Book, 44th Annual Meeting of the American Society of Hematology. Philadelphia, PA, December 6-10, 2002:136.
12. Myelodysplastic syndrome. In: Beers MK, Berkow R, eds. The Merck Manual of Diagnosis and Therapy, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories, 1999:953.
13. Davis L. Let it bleed. Discover July, 2002:20.
14. Storb RF, Chairman, Non-myeloablative conditioning regimens for allogeneic stem cell transplantation. In: Schechter GP, ed. Hematology 1999. American Society of Hematology Education Program Book, 41st Annual Meeting of the American Society of Hematology. New Orleans, LA: December 3-7, 1999:396.
15. Wimer BM. Mitogen hypotheses revisited: Enhancement of allograft tolerance and replacement of transplantation procedures in treating cancer. Cancer Biother Radiopharm 2000;15:207.
16. Storb RF. Non-myeloablative transplants for malignant disease. Hematopoietic cell transplantation in elderly patients with hematologic cancer: Substituting graft-versus-tumor effects for high-dose cytotoxic therapy. In: Schechter GP, ed. Hematology 2001. American Society of Hematology Education Program Book, 43rd Annual Meeting of the American Society of Hematology. Orlando, FL, December 7-11, 2001:375.
17. Wimer, BM. Therapeutic immunostimulating effects of plant mitogens exemplified by the L4 isolectin of PHA. Cancer Biother Radiopharm 1997;12:195.
18. Wright K. Free radical (about Dr. Bruce Ames of UC Berkeley). Discover, October 2002.
19. Alzheimer's disease. In: Beers MK, Berkow R, eds. The Merck Manual of Diagnosis and Therapy, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories, 1999:1395.
20. Ritter M. Researchers eye brain cell-depression link. The Associated Press, October 28, 2002.
21. Waldholz M. Drugs spur growth in damaged nerve cells. The Wall Street Journal, December 5, 2002.
22. Hamilton DP. "Fingerprints" of cancer cells could predict disease's spread. The Wall Street Journal Online, December 19, 2002; (see www.wsj.com).
23. Alibek K, Handelman S. Biohazard. New York: Random House, Inc., 1999:322 pp.